Israel Englander’s MDxHealth MDXH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$93.8K Sell
228,510
-316,218
-58% -$424K ﹤0.01% 5512
2026
Q1
$1.25M Buy
544,728
+427,897
+366% +$1.45M ﹤0.01% 4216
2025
Q4
$417K Buy
116,831
+89,553
+328% +$354K ﹤0.01% 5060
2025
Q3
$127K Buy
+27,278
New +$83.9K ﹤0.01% 5656
2024
Q1
Sell
-11,432
Closed -$45K 6461
2023
Q4
$45K Sell
11,432
-12,797
-53% -$38.3K ﹤0.01% 5497
2023
Q3
$68.8K Sell
24,229
-6,384
-21% -$21.2K ﹤0.01% 5420
2023
Q2
$104K Buy
+30,613
New +$112K ﹤0.01% 5320

Other funds holding MDXH

Israel Englander's MDXH Position: Q2 2026 in Review

Israel Englander reduced its MDxHealth (MDXH) stake by 58% in Q2 2026, selling an estimated $424K and leaving 228,510 shares worth $93.8K. The position accounts for ﹤0.01% of the portfolio, ranked #5512.

Israel Englander first reported a position in MDXH in Q2 2023 and has held it in 7 quarters since. The position peaked at $1.25M in Q1 2026. 26 funds tracked by Wall St. Rank hold MDXH as of Q2 2026.

  • Israel Englander held 228,510 shares of MDxHealth worth $93.8K as of Q2 2026.
  • Israel Englander sold 316,218 MDxHealth shares in Q2 2026, an estimated $424K.
  • MDxHealth made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #5512 holding.
  • Israel Englander first reported a position in MDxHealth in Q2 2023 and has held it in 7 quarters since.
  • Israel Englander's MDxHealth position peaked at $1.25M in Q1 2026.
  • 26 funds tracked by Wall St. Rank held MDxHealth as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.